arrow_back Back to App

Greater Drug Discount Transparency: Lower Costs for Patients

This act aims to increase transparency regarding drug discounts and rebates negotiated by pharmacy benefit managers (PBMs). Citizens will gain access to information on how these discounts affect drug prices, potentially leading to lower healthcare costs. The information will be publicly available while protecting sensitive data.
Key points
Public disclosure of drug discount and rebate information starting January 1, 2022.
Data will be available on the Department of Health and Human Services website, grouped by drug class.
The goal is to allow comparison of how pharmacy benefit managers pass on negotiated discounts to patients and insurance plans.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3682
Sponsor: Rep. Spanberger, Abigail Davis [D-VA-7]
Process start date: 2021-06-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Improving Transparency to Lower Drug Costs Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3682.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-06-01.

What are the main provisions?

Key points include:

  • Public disclosure of drug discount and rebate information starting January 1, 2022.
  • Data will be available on the Department of Health and Human Services website, grouped by drug class.
  • The goal is to allow comparison of how pharmacy benefit managers pass on negotiated discounts to patients and insurance plans.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Spanberger, Abigail Davis [D-VA-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health